Skip to search formSkip to main contentSkip to account menu

SC 53228

Known as: SC-53228 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: Impact upon Leukotriene B4- and 12(R)-HETE- mediated events
Leukotriene B4 (LTB4) and 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE] are proinflammatory products of arachidonic acid… 
1995
1995
Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228:
Inflammatory bowel disease is a chronic inflammatory disorder of the gastrointestinal tract that includes ulcerative colitis and… 
1995
1995
Dermal inflammation in primates, mice, and guinea pigs: Attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228
Granulocyte infiltration is a prominent feature of human psoriasis. Psoriatic lesional skin contains abnormally high amounts of… 
1995
1995
The pharmacokinetics and metabolism of SC-53228, a specific leukotriene B4 receptor antagonist
SC-53228, ( + ) 7 [ 3 [ 2 ( C y c l o p r o p y l m e t h y l ) 3 M e t h o x y 4 [ (Me thy l aminoca rbony l ]phenoxy]p ropoxy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)